Enveric Biosciences Inc (ENVB) Quote

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease

ENVB under $2

ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783

ENVB: The Pro's are now workin' on their THIRD-NICE-FLIP behind this (easy money) puppy today!!! (I.e., one 100%-profit flip in the Pre-M, & now TWO circa 25-to-30%-profit flips in the Open-M!!! Yet STUPID traders cry about "Wash Trades". L.M.M.F.A.O.!!!!!)

ENVB: Heck, "Wash-Trades" keep those PROFITS nice & CLEAN!!!!

Wash trade du jour

ENVB: I'm buyin' latte's for everyone later today, up on the MOON!!!

ENVB: 3-bagger from here, whether anybody likes it or not!! (Just the way it goes, these days!!)

Nasty trap

Short

The term sheets further provide that, Enveric could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) applications and completing Phases I through III testing of the licensed products. Royalty rates on each of the three licenses could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The compound classes under the term sheets come from two of the seven portfolios of preclinical molecules that Enveric recently unveiled as available for out-licensing. Numerous molecules and classes remain available for additional out-licensing opportunities.

“Patients living with serious mental health conditions have seen insufficient innovation for far too long, and we are excited for the opportunity to progress several of the novel compounds generated using our drug discovery engine,” said Joseph Tucker, Ph.D., Director and CEO of Enveric. “We look forward to working with our partner, and we are confident in their leadership and capabilities to work on further developing these drug candidates to advance treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and could demonstrate the value creation from Enveric’s discovery capabilities and proprietary PsyAI™ and Psybrary™ platforms, which have already generated an impressive library of compounds targeting a variety of CNS disorders.”

ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783

Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property

What's the patent application number?

IG

4.96 to 3 blink of any eye

7.52 easy

$4-$5.75. Done for the day. Wooo

Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug

Nice flipper

Ok it cooled off
Five dollar run

Now a Rug Pooool candidate lol... Now it's too dangerous... It can run 4+ but it can dump too as seen from 4.20s to 3.20s in all of 15 seconds

Another rip or another dump, only the devil knows

Good call. Ran to 4.20s and dumped to 3.20s

I’m out

https://stockcharts.com/h-sc/ui?s=envb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/envb/opinion

Open gap at $1.52

There's another pullback

Ooooooops!! (iHub posting error, glitch, etc.).

ENVB: I'm workin' on an ANSWER to your question right now, Sir. (See my 'Chart' on this, below.)

WALL @ 3.50 JUST TAKEN OUT

Anyone smell a bait and pull? Lol or do we forsee $5- 6

ENVB: See ya-all up on the MOON later, Folks!!

Same. I expect pullbacks and runs if the volume stays consistent.. which means mass flipping

Watching

This could run 5 - 6 today.

Sell down now

Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

The RS already took place. Don't understand why my post would need to ve deleted

But gonna be a nice entry soon imo

Rs and dilution followed right after wow??

Reverse split just anounced

What are other biotech stocks I’m not familiar with this sector. Appreciate your feedback MASTERULTRA you seem to know about these.

Seriously, WTF!!! this company should be trending higher due to 04/20...

I fucking hope the people who short this or manipulate this gets Karma.

The douche canoe Dj front load of the day lol

$ENVB Added..looks like interest building here..

Back on watch .. Bottom or how much lower?

ENVB

Agreed.

This company is a total loser with zero revenue.

Absolute embarrassment.

New CFO Carter Ward ran this company into the ground in just 9 months.

Delist imminent or reverse split.

Delist imminent or reverse split.

ENVB - Thursday Rundown, Friday Expectations

In for a little, bouncing bottom perhaps.

ENVB

Enveric Biosciences to Participate in Upcoming Investor Conferences in September 2021

Source: PR Newswire (US)
NAPLES, Fla., Sept. 20, 2021 /PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform for the mind and body using psychedelics and cannabinoids, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming investor conferences:

Maxim's Advances in Mental Health Virtual Conference
Wednesday, September 22nd at 10:00 a.m. ET
Panel titled: Next Gen Psychedelics: Novel Chemical Entities
To attend, register here

Benzinga's Healthcare Small Cap Virtual Conference
Thursday, September 30th at 3:40 p.m. ET
To attend, register here

For more information about the conferences, or to schedule a one-on-one meeting with Enveric's management, please contact your appropriate representative directly, or send an email to Maxim at jthompson@maximgrp.com, Benzinga at VIPevents@benzinga.com, or KCSA Strategic Communications at EnvericBio@kcsa.com.

About Enveric Biosciences
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more. For more information, please visit www.enveric.com.

Investor Contacts
Valter Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
valter@kcsa.com / asoss@kcsa.com

Media Contacts
Caitlin Kasunich / Raquel Cona
KCSA Strategic Communications
212.896.1241 / 212.896.1204
ckasunich@kcsa.com / rcona@kcsa.com

Cision View original content:https://www.prnewswire.com/news-releases/enveric-biosciences-to-participate-in-upcoming-investor-conferences-in-september-2021-301380168.html

SOURCE Enveric Biosciences


Copyright 2021 PR Newswire